Rheumatoid arthritis

OMERACT: guardians of the path to improved outcome measures

Sponsored by AbbVie Pty Ltd

Clinical trials are only as credible as their endpoints In the 1980s, there was considerable variation in the way clinical measures were used to make judgments about the effectiveness of treatment.1 It is because of this notion that OMERACT, or ‘Outcome measures in Rheumatology’ – an international initiative established in 1992 – began to redefine ...

Already a member?

Login to keep reading.

© 2021 the limbic